- Home
- SBFM vs ADIL Comparison
SBFM vs ADIL Comparison
Compare SBFM & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- ADIL
- Stock Information
- Founded
- SBFM 2006
- ADIL 2010
- Country
- SBFM United States
- ADIL United States
- Employees
- SBFM N/A
- ADIL N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- ADIL Health Care
- Exchange
- SBFM Nasdaq
- ADIL Nasdaq
- Market Cap
- SBFM 4.9M
- ADIL 4.3M
- IPO Year
- SBFM N/A
- ADIL 2018
- Fundamental
- Price
- SBFM $1.55
- ADIL $0.72
- Analyst Decision
- SBFM Strong Buy
- ADIL Strong Buy
- Analyst Count
- SBFM 1
- ADIL 1
- Target Price
- SBFM $15.00
- ADIL $8.00
- AVG Volume (30 Days)
- SBFM 4.3M
- ADIL 50.4K
- Earning Date
- SBFM 05-19-2025
- ADIL 05-13-2025
- Dividend Yield
- SBFM N/A
- ADIL N/A
- EPS Growth
- SBFM N/A
- ADIL N/A
- EPS
- SBFM N/A
- ADIL N/A
- Revenue
- SBFM $34,874,283.00
- ADIL N/A
- Revenue This Year
- SBFM $192.48
- ADIL N/A
- Revenue Next Year
- SBFM N/A
- ADIL N/A
- P/E Ratio
- SBFM N/A
- ADIL N/A
- Revenue Growth
- SBFM 44.75
- ADIL N/A
- 52 Week Low
- SBFM $1.17
- ADIL $0.58
- 52 Week High
- SBFM $33.60
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- SBFM 44.81
- ADIL 50.77
- Support Level
- SBFM $1.17
- ADIL $0.65
- Resistance Level
- SBFM $1.59
- ADIL $0.74
- Average True Range (ATR)
- SBFM 0.19
- ADIL 0.07
- MACD
- SBFM 0.03
- ADIL 0.00
- Stochastic Oscillator
- SBFM 52.84
- ADIL 61.36
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.